左心補助循環装置の世界市場レポート 2025年

左心補助循環装置市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で25億2,000万米ドルに成長します。予測期間の成長は、適応症の拡大、心不全症例の増加、患者転帰の向上、市場承認や規制の変更、目的地治療の重視などに起因します。予測期間における主な動向としては、植え込み技術の進歩、デュアルポンプシステムの開発、目的地治療としての使用拡大、感染リスクの最小化重視、心不全管理プログラムとの統合、抗凝固管理の改善などが挙げられます。

心血管疾患の有病率の増加は、今後数年間の左室補助循環装置市場の成長を促進すると予想されます。心血管疾患には、冠動脈性心疾患や先天性心疾患など、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。心不全が進行した場合、左室補助循環装置は、血液を体の組織に送り出す役割を担う心臓の左心室をサポートします。例えば、2024年3月に英国の政府機関であるOffice for Health Improvement and Disparitiesが発表したデータによると、2023年にイングランドで冠動脈性心疾患（CHD）と診断された人は186万2500人（3％）を超えていました。さらに、2022年12月、ニューヨーク政府のデータにより、米国では心臓病が年間約697,000人の死亡の原因となっており、これは死亡者の5人に1人に相当することが明らかになった。毎年、約80万5,000人のアメリカ人が心臓発作を経験しており、60万5,000人が初めての心臓発作、20万人が過去の心臓発作によるものです。したがって、心血管疾患の有病率の上昇が左心補助循環装置市場の成長を後押ししています。

ヘルスケア支出の増加は、今後の左心補助循環装置市場の成長を促進すると予想されます。ヘルスケア支出には、健康を中心とした保健サービス、家族計画活動、栄養プログラム、緊急支援などの提供に関連するすべての費用が含まれます。ヘルスケア支出の増加は、左心補助循環装置を含むさまざまな健康関連製品の進歩・開発を促進します。ヘルスケア支出の増加は、左心補助循環装置市場の成長にプラスの影響を与えると思われます。例えば、2022年、英国の国家統計機関であるOffice for National Statisticsは、英国のヘルスケア支出が約3,548億8,000万米ドル（2,830億英ポンド）に達し、2021年の支出と比較して名目で0.7%の増加を反映したと報告しました。このように、ヘルスケア支出の増加が左室補助循環装置市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界左心補助循環装置 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の左心補助循環装置市場：成長率分析
• 世界の左心補助循環装置市場の実績：規模と成長, 2019-2024
• 世界の左心補助循環装置市場の予測：規模と成長, 2024-2029, 2034F
• 世界左心補助循環装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の左心補助循環装置市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的左心補助循環装置
• 埋め込み型左心補助循環装置
• 世界の左心補助循環装置市場フローの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脈動する
• 非脈動性
• 世界の左心補助循環装置市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 回復への橋渡し（BTR）療法
• ブリッジ・トゥ・トランスプラント（BTT）療法
• デスティネーションセラピー
• ブリッジ・トゥ・キャンディダシー（BTC）療法
• 世界の左心補助循環装置市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓病センター
• 病院
• 世界の左心補助循環装置市場経皮的左心室補助装置のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一時的な経皮的デバイス
• 永久経皮デバイス
• 世界の左心補助循環装置市場、植込み型左心室補助装置のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 連続フロー装置
• 脈動流装置

第7章 地域別・国別分析

• 世界の左心補助循環装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の左心補助循環装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 左心補助循環装置市場：競合情勢
• 左心補助循環装置市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
  • MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• LivaNova Plc
• Thoratec Corporation
• Abiomed Inc
• Transonic Systems
• Berlin Heart GmbH
• BioVentrix
• Cleveland Heart Inc.
• Jarvik Heart Inc.
• CorWave SA
• SynCardia Systems LLC
• NuPulseCV Inc.
• Fineheart
• Procyrion Inc
• Carmat SA
• BiVACOR Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 左心補助循環装置市場2029：新たな機会を提供する国
• 左心補助循環装置市場2029：新たな機会を提供するセグメント
• 左心補助循環装置市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including the left ventricular assist devices industry's global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends, and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.6 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to post-market surveillance and data, reduction in device size and noise, awareness and education programs, increased physician experience, and adoption in bridge therapy

The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanded indications, a rise in heart failure cases, enhanced patient outcomes, market approval and regulatory changes, focus on destination therapy. Major trends in the forecast period include advancements in implantation techniques, development of dual-pump systems, growing use as a destination therapy, focus on minimizing infection risks, integration with heart failure management programs, and improved anticoagulation management.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the left ventricular assist device market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease and congenital heart disease, among others. In cases of advanced heart failure, a left ventricular assist device supports the heart's left ventricle, which is responsible for pumping blood to the body's tissues. For example, in March 2024, data released by the Office for Health Improvement and Disparities, a UK government agency, indicated that there were over 1,862,500 individuals (3%) diagnosed with coronary heart disease (CHD) in England in 2023. Additionally, in December 2022, data from the New York government revealed that heart disease is responsible for approximately 697,000 deaths annually in the United States, equating to 1 in every 5 fatalities. Each year, around 805,000 Americans experience a heart attack, with 605,000 being their first and 200,000 resulting from previous heart attacks. Therefore, the rising prevalence of cardiovascular diseases is fueling the growth of the left ventricular assist device market.

The increase in healthcare expenditures is expected to drive the growth of the left ventricular assist device market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare spending can facilitate the advancement and development of various health-related products, including left ventricular assist devices. As healthcare expenditures rise, they will positively impact the growth of the left ventricular assist device market. For example, in 2022, the Office for National Statistics, a UK national statistics organization, reported that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to spending in 2021. Thus, the rise in healthcare expenditures is propelling the growth of the left ventricular assist device market.

Leading companies in the left ventricular assist devices market are focusing on developing technologies like power management units (PMUs) to improve the efficiency, reliability, and longevity of these devices. A power management unit (PMU) is an integrated circuit responsible for regulating and managing the power supply and distribution to various components within electronic devices. For example, in June 2022, Renesas Electronics, a semiconductor manufacturer based in Japan, introduced the SmartBond DA1470x. This family of products marks a significant advancement in Bluetooth Low Energy (BLE) technology, offering developers a versatile platform for creating innovative IoT products while optimizing costs and enhancing performance. The high level of integration in the SmartBond DA1470x simplifies design, boosts reliability, and shortens time-to-market across various applications.

Major companies in the left ventricular assist device industry are significantly investing in research, development, and early feasibility trials for their Total Artificial Heart (TAH). This substantial investment aligns with long-term goals, as demonstrated by BiVACOR, a US-based medical technology company that secured $18 million in funding for TAH development in March 2023. Led by Cormorant Asset Management and OneVentures, these funds will support research, early feasibility trials, and key executive hires. The BiVACOR TAH, designed for severe biventricular heart failure, incorporates advancements from Left Ventricular Assist Device (LVAD) technology, signaling a shift toward durable rotary blood pumps.

In December 2022, Johnson & Johnson, a prominent US-based pharmaceutical and medical technology company, completed the acquisition of Abiomed Inc for $16.6 billion. This strategic acquisition aimed to expand Johnson & Johnson's presence in the high-growth cardiovascular markets. Abiomed Inc., a US-based medical device technology company, specializes in providing circulatory and oxygenation support devices, including ventricular assist technology that pumps blood from the left ventricle (LV).

Major companies operating in the left ventricular assist devices market include Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp

North America was the largest region in the left ventricular assist devices market in 2024. The regions covered in the left ventricular assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Transcutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
• 2) By Type Of Flow: Pulsatile; Non-Pulsatile
• 3) By Application: Bridge-To-Recovery (BTR) Therapy; Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Candidacy (BTC) Therapy
• 4) By End-User: Cardiology Centers; Hospitals
• Subsegments:
• 1) By Transcutaneous Left Ventricular Assist Devices: Temporary Transcutaneous Devices; Permanent Transcutaneous Devices
• 2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices; Pulsatile Flow Devices
• Companies Mentioned: Abbott Laboratories; Medtronic plc.; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Left Ventricular Assist Devices Market Characteristics

3. Left Ventricular Assist Devices Market Trends And Strategies

4. Left Ventricular Assist Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Left Ventricular Assist Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Left Ventricular Assist Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Left Ventricular Assist Devices Market Growth Rate Analysis
• 5.4. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Left Ventricular Assist Devices Total Addressable Market (TAM)

6. Left Ventricular Assist Devices Market Segmentation

• 6.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcutaneous Left Ventricular Assist Devices
• Implantable Left Ventricular Assist Devices
• 6.2. Global Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulsatile
• Non-Pulsatile
• 6.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bridge-To-Recovery (BTR) Therapy
• Bridge-To-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-To-Candidacy (BTC) Therapy
• 6.4. Global Left Ventricular Assist Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiology Centers
• Hospitals
• 6.5. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Transcutaneous Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Temporary Transcutaneous Devices
• Permanent Transcutaneous Devices
• 6.6. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Implantable Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Flow Devices
• Pulsatile Flow Devices

7. Left Ventricular Assist Devices Market Regional And Country Analysis

• 7.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Left Ventricular Assist Devices Market

• 8.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Left Ventricular Assist Devices Market

• 9.1. China Left Ventricular Assist Devices Market Overview
• 9.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Left Ventricular Assist Devices Market

• 10.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Left Ventricular Assist Devices Market

• 11.1. Japan Left Ventricular Assist Devices Market Overview
• 11.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Left Ventricular Assist Devices Market

• 12.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Left Ventricular Assist Devices Market

• 13.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Left Ventricular Assist Devices Market

• 14.1. South Korea Left Ventricular Assist Devices Market Overview
• 14.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Left Ventricular Assist Devices Market

• 15.1. Western Europe Left Ventricular Assist Devices Market Overview
• 15.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Left Ventricular Assist Devices Market

• 16.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Left Ventricular Assist Devices Market

• 17.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Left Ventricular Assist Devices Market

• 18.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Left Ventricular Assist Devices Market

• 19.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Left Ventricular Assist Devices Market

• 20.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Left Ventricular Assist Devices Market

• 21.1. Eastern Europe Left Ventricular Assist Devices Market Overview
• 21.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Left Ventricular Assist Devices Market

• 22.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Left Ventricular Assist Devices Market

• 23.1. North America Left Ventricular Assist Devices Market Overview
• 23.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Left Ventricular Assist Devices Market

• 24.1. USA Left Ventricular Assist Devices Market Overview
• 24.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Left Ventricular Assist Devices Market

• 25.1. Canada Left Ventricular Assist Devices Market Overview
• 25.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Left Ventricular Assist Devices Market

• 26.1. South America Left Ventricular Assist Devices Market Overview
• 26.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Left Ventricular Assist Devices Market

• 27.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Left Ventricular Assist Devices Market

• 28.1. Middle East Left Ventricular Assist Devices Market Overview
• 28.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Left Ventricular Assist Devices Market

• 29.1. Africa Left Ventricular Assist Devices Market Overview
• 29.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

• 30.1. Left Ventricular Assist Devices Market Competitive Landscape
• 30.2. Left Ventricular Assist Devices Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

31. Left Ventricular Assist Devices Market Other Major And Innovative Companies

• 31.1. LivaNova Plc
• 31.2. Thoratec Corporation
• 31.3. Abiomed Inc
• 31.4. Transonic Systems
• 31.5. Berlin Heart GmbH
• 31.6. BioVentrix
• 31.7. Cleveland Heart Inc.
• 31.8. Jarvik Heart Inc.
• 31.9. CorWave SA
• 31.10. SynCardia Systems LLC
• 31.11. NuPulseCV Inc.
• 31.12. Fineheart
• 31.13. Procyrion Inc
• 31.14. Carmat SA
• 31.15. BiVACOR Inc

32. Global Left Ventricular Assist Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

34. Recent Developments In The Left Ventricular Assist Devices Market

35. Left Ventricular Assist Devices Market High Potential Countries, Segments and Strategies

• 35.1 Left Ventricular Assist Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Left Ventricular Assist Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Left Ventricular Assist Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer